Navigation Links
Chimerix to Present at Cowen and Company's 32nd Annual Health Care Conference
Date:3/5/2012

vir-diphosphate and has broad spectrum activity against dsDNA viruses in vitro. CMX001 has completed Phase 2 clinical development for the prophylaxis of CMV and is in Phase 2 development for the preemption and treatment of adenovirus infection in hematopoietic stem cell transplant recipients. Antiviral activity results from completed and ongoing studies, coupled with the lack of myelotoxicity and nephrotoxicity seen in currently available therapies, indicate that CMX001 has the potential to improve outcomes for immunosuppressed patients. To date, more than 700 patients have been dosed with CMX001 in placebo-controlled clinical trials and open-label treatment protocols.

In addition to the company's development of its lead candidate, CMX001 is also being developed as a medical countermeasure in the event of a smallpox release, with the potential to provide an important therapeutic option for the 80 million people in the US currently estimated to be immunocompromised, or a household contact of a contraindicated individual, and thus not candidates to receive a smallpox vaccine (see http://www.bt.cdc.gov/agent/smallpox/vaccination/contraindications-clinic.asp). Chimerix has received federal funding for the development of CMX001 as a medical countermeasure against smallpox from the National Institute of Allergy and Infectious Diseases under Grant No. U01-A1057233 and from the Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services, under Contract No. HHSO100201100013C.

Chimerix's second clinical-stage antiviral compound, CMX157, is a Lipid-Antiviral-Conjugate that delivers high intracellular levels of the active antiviral agent tenofovir-diphosphate. CMX157 is in development as a potent nucleoside analogue against HIV and
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
2. Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
3. Chimerix to Present at Two Upcoming Investor Conferences
4. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
5. Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
6. Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
7. Chimerix to Present at 9th Annual BIO Investor Forum
8. Chimerix Reaffirms Its Commitment to CMX001 as a Medical Countermeasure for Smallpox and Broad-Spectrum Antiviral Agent
9. Chimerix to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
10. Chimerixs Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety and Tolerability
11. Chimerix Commences CMX001 Open-Label Clinical Study for the Treatment of Patients With Life-Threatening or Serious dsDNA Viral Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... England , April 17, 2015 ... genomics company announced today that their presence at the 2015 ... include a presentation by co-founder Nitzan Rosenfeld and ... also attending April 18 th - 22 nd . ... in plasma using ctDNA , forms part of ...
(Date:4/17/2015)... 17, 2015 ASSESS shows   ... is a viable alternative to tumour biopsy   ... patients with advanced NSCLC   AstraZeneca today presented ... circulating tumour DNA (ctDNA) testing for epidermal growth factor receptor ... cell lung cancer (NSCLC) in clinical practice. [ 1 ...
(Date:4/17/2015)... , April 17, 2015  Over the next five years, ... to grow, with ArcView predicting that 14 more states will ... marijuana. The U.S. market for legal cannabis grew 74 percent ... 2013. Analysts project the market could grow more than fourfold ... states soften their stance on marijuana. Cannabiz Mobile ...
Breaking Medicine Technology:Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4Cannabiz Mobile Analyst Brief: Next Big Thing by Torus IR Issued by BrokerBank Securities, Inc. 2
... Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced ... Healthcare Conference on Friday, September 17, 2010 at 8:35 a.m. ... the Four Seasons in Boston.  Steve Worland, Ph.D., President and ... Anadys and its clinical development programs. Dr. Worland ...
... SYK ) announced that it will host a ... Eastern Time, to discuss the Company,s operating results for the ... Operating results for the quarter ended September 30, 2010 will ... participate in the conference call dial 866-270-6057(domestic) or ...
Cached Medicine Technology:Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences 2Stryker to Host Conference Call on October 19, 2010 2
(Date:4/19/2015)... Autocarinsurancecheap.com has released a new blog post ... protection for vulnerable family members. , Accidental death ... or is disabled in an accident. The policy will ... an auto insurance plan. However, AD&D insurance can also ... life insurance policy. The newly blog post presents the ...
(Date:4/19/2015)... Carinsurancesavings.biz has released a new blog post explaining ... who have diabetes. , Clients who have diabetes ... newly released blog post explains how diabetes influences auto ... low cost coverage. , It is now possible ... single website. Clients can visit http://carinsurancesavings.biz for ...
(Date:4/19/2015)... 19, 2015 McCann Investigations, a Texas-based ... the publication of white paper Married, but Dating: ... As online media provides a unique environment of privacy, ... specifically targeting adulterous spouses has emerged. Social platforms ... as easy as shopping online. Dating sites and ...
(Date:4/18/2015)... York, NY (PRWEB) April 19, 2015 ... experienced strong growth during the past five years. The ... individuals who are unable to fully care for themselves, ... the growing need for dementia care for seniors with ... to rise at an annualized rate of 4.1% to ...
(Date:4/18/2015)... "I recognized the need for a better ... an inventor from Cincinnati, Ohio. "This need inspired me ... the Slyde Door to offer an alternative to the ... provides convenient storage space for an evacuation stretcher. The ... patients. , This offers added peace of mind ...
Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Provide Financial Security! 2Health News:Finding Low Cost Auto Insurance for Diabetic Drivers! 2Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 3
... 10 Mark Ganz, President and Chief,Executive Officer of ... of,thought leaders and health policy experts convened by The ... reframe and broaden the,national dialogue on health care reform ... The Aspen Health Stewardship Project will expand the health ...
... Women under the age of forty with breast cancer who ... as adjuvant chemotherapy, may not be benefiting from these drugs. ... levels of hormones such as estrogen, according to research published ... cancer at a young age is very worrying in terms ...
... urges Congress to,pass legislation this year to ... WASHINGTON, Oct. 10 The Health IT ... and former,Representative Nancy Johnson, today applauded Representatives ... that will bring health,information technology to all ...
... Oct. 10 XShares Advisors LLC, on behalf ... 12-month supporting,relationship with the Parkinson,s Disease Foundation (PDF), ... public advocacy. XShares, platinum level support of ... and Clinical Advances in Quality of Life,and exclusive ...
... an investment,company with a family of 20 fund portfolios, ... of its 19 currently NYSE-listed,HealthShares exchange-traded funds (ETFs) to ... requirement to transfer of all ETFs to the,NYSE Arca ... prior to,October 31, 2007. The transfer is expected to ...
... SpectraScience, Inc. (OTC,Bulletin Board: SCIE) announced today ... of the Company,s quality system from the Notified,Body ... reference to,Annex II.3 of the European directive 93/42/EEC. ... issued. Jim Hitchin the Company,s CEO said, ...
Cached Medicine News:Health News:Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship 2Health News:Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship 3Health News:Cancer conflict with chemotherapy treatment 2Health News:Health IT Now! Coalition Applauds Representatives Eshoo and Rogers for Introducing Health IT Legislation 2Health News:XShares Supports Parkinson's Disease Foundation 50th Anniversary Educational Symposium 2Health News:XShares Supports Parkinson's Disease Foundation 50th Anniversary Educational Symposium 3Health News:XShares Supports Parkinson's Disease Foundation 50th Anniversary Educational Symposium 4Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 2Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 3Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 4Health News:SpectraScience Receives Final European Certification 2
ESR-Vacuum Tubes are evacuated tubes used for the collection of venous blood. ESR-Vacuum Tubes are used to transport and process blood for testing the Erythrocyte Sedimentation Rate (ESR) of whole bl...
... contain a buffered sodium citrate ... a citrate concentration of 0.109 ... (3.8%). The mixing ratio is ... 9 parts blood. In addition ...
Plastic Citrate Tube, .109M / 3.2%...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: